Current research trends into the effect of climate change on civil engineering infrastructures: A bibliometric review.

Autor: Kalogeraki, M, Antoniou, F

Publikováno v: IOP Conference Series: Earth & Environmental Science; 2022, Vol. 1123 Issue 1, p1-10, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Autor: Rondeau V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Kalogeraki M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Roland L; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Nader ZA; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Gourhand V; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bonaud A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Lemos J; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Khamyath M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Moulin C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Schell B; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Delord M; Direction à la Recherche Clinique et à l'Innovation, Centre Hospitalier de Versailles, Le Chesnay, France., Bidaut G; Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Lecourt S; INSERM U1279, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France., Freitas C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Anginot A; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Mazure N; Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France., McDermott DH; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Parietti V; Université Paris Cité, UMS Saint-Louis INSERM U53/UAR2030, Paris, France., Setterblad N; Université Paris Cité, UMS Saint-Louis INSERM U53/UAR2030, Paris, France., Dulphy N; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Bachelerie F; Université Paris-Saclay, INSERM, Inflammation, Microbiome and Immunosurveillance, Orsay, France., Aurrand-Lions M; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.; Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France., Stockholm D; PSL Research University, EPHE, Paris, France.; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France., Lobry C; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U944, Paris, France., Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Espéli M; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France., Mancini SJC; Univ Rennes, INSERM, EFS, UMR S1236, Rennes, France., Balabanian K; Université Paris Cité, Institut de Recherche Saint-Louis, INSERM U1160, Paris, France.; OPALE Carnot Institute, Organization for Partnerships in Leukemia, Hôpital Saint-Louis, Paris, France.

Publikováno v: Science signaling [Sci Signal] 2024 Oct 29; Vol. 17 (860), pp. eadl5100. Date of Electronic Publication: 2024 Oct 29.